Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Historic Work In Process for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Q4 2019 value amounting to $392000.0.

Ironwood Pharmaceuticals' Work In Process changed N/A to $392000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $392000.0, marking a year-over-year change of. This contributed to the annual value of $392000.0 for FY2019, which is N/A changed from last year.
Latest data reveals that Ironwood Pharmaceuticals reported Work In Process of $392000.0 as of Q4 2019.
In the past 5 years, Ironwood Pharmaceuticals' Work In Process registered a high of $707000.0 during Q3 2019, and its lowest value of $71000.0 during Q4 2016.